Julia Ellis-Kahana1, Andrew D Sparks1, Alexis C Gimovsky1, Andra H James2, Homa K Ahmadzia3. 1. George Washington University, School of Medicine and Health Sciences, Department of Obstetrics and Gynecology, Washington, DC, United States of America. 2. Duke University Medical Center, Department of Obstetrics and Gynecology, Durham, NC, United States of America. 3. George Washington University, School of Medicine and Health Sciences, Department of Obstetrics and Gynecology, Washington, DC, United States of America. Electronic address: hAhmadzia@mfa.gwu.edu.
Abstract
INTRODUCTION: Venous thromboembolism (VTE) in pregnancy and postpartum is a leading cause of maternal morbidity and mortality in developed countries, where obesity is a known risk for this complication. Current guidelines vary in which patients qualify for VTE prophylaxis, precluding a uniform approach for management. We sought to derive a risk prediction model for VTE in obese pregnant women. MATERIALS AND METHODS: We performed a retrospective cohort analysis using the Consortium on Safe Labor (CSL) database. Women ages 16-45 who were pregnant with singletons and had an obese body mass index (>30 kg/m2) were included in our study population. Multivariable logistic regression was used in order to identify predictors of venous thromboembolism. RESULTS: Of the 83,500 women who met inclusion criteria, on average women were 27.8 years old, 38.6 weeks gestation, with body mass index of 35.8, and cesarean delivery incidence of 35.2%. 109 women (0.13%) experienced a VTE event. Independent predictors of VTE in our final multivariable predictive model included: mode of delivery, body mass index, pregestational diabetes, chronic heart disease, preeclampsia, blood transfusion (intrapartum or postpartum), prenatal history of thromboembolic disorder, and postpartum maternal length of stay. A receiver operating characteristic curve was developed to assess the model; area under the curve was 0.826. CONCLUSIONS: We developed a strong predictive model using a large, retrospective database to distinguish risk of VTE in obese pregnant women, which may provide the foundation for future protocol development of obstetrical thromboprophylaxis in obese women.
INTRODUCTION:Venous thromboembolism (VTE) in pregnancy and postpartum is a leading cause of maternal morbidity and mortality in developed countries, where obesity is a known risk for this complication. Current guidelines vary in which patients qualify for VTE prophylaxis, precluding a uniform approach for management. We sought to derive a risk prediction model for VTE in obese pregnant women. MATERIALS AND METHODS: We performed a retrospective cohort analysis using the Consortium on Safe Labor (CSL) database. Women ages 16-45 who were pregnant with singletons and had an obese body mass index (>30 kg/m2) were included in our study population. Multivariable logistic regression was used in order to identify predictors of venous thromboembolism. RESULTS: Of the 83,500 women who met inclusion criteria, on average women were 27.8 years old, 38.6 weeks gestation, with body mass index of 35.8, and cesarean delivery incidence of 35.2%. 109 women (0.13%) experienced a VTE event. Independent predictors of VTE in our final multivariable predictive model included: mode of delivery, body mass index, pregestational diabetes, chronic heart disease, preeclampsia, blood transfusion (intrapartum or postpartum), prenatal history of thromboembolic disorder, and postpartum maternal length of stay. A receiver operating characteristic curve was developed to assess the model; area under the curve was 0.826. CONCLUSIONS: We developed a strong predictive model using a large, retrospective database to distinguish risk of VTE in obese pregnant women, which may provide the foundation for future protocol development of obstetrical thromboprophylaxis in obesewomen.
Authors: Mary E D'Alton; Alexander M Friedman; Richard M Smiley; Douglas M Montgomery; Michael J Paidas; Robyn D'Oria; Jennifer L Frost; Afshan B Hameed; Deborah Karsnitz; Barbara S Levy; Steven L Clark Journal: Anesth Analg Date: 2016-10 Impact factor: 5.108
Authors: Alyshah Abdul Sultan; Laila J Tata; Joe West; Linda Fiaschi; Kate M Fleming; Catherine Nelson-Piercy; Matthew J Grainge Journal: Blood Date: 2013-04-02 Impact factor: 22.113
Authors: Abdullah Pandor; Jahnavi Daru; Beverley J Hunt; Gill Rooney; Jean Hamilton; Mark Clowes; Steve Goodacre; Catherine Nelson-Piercy; Sarah Davis Journal: BMJ Open Date: 2022-10-12 Impact factor: 3.006